ACHN Pharmaceuticals Inc.

Overview

ACHN Pharmaceuticals Inc. is a biopharmaceutical company focused on developing innovative therapies to address unmet medical needs in various therapeutic areas. The company is committed to research and development to bring new drugs to market, primarily focusing on rare and complex diseases.

Therapeutic areas

API / Drug Master Files

ACHN Pharmaceuticals Inc. holds 2 active (2 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• CYSTEAMINE HYDROCHLORIDEActive2022-06-03
• CYSTEAMINE BITARTRATEActive2013-09-05

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to ACHN Pharmaceuticals Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.